Thank you for sharing. I wasn't familiar with how
Post# of 148187
While most of us are not excited about CYDY spending more money of preclinical trials at this point, I'm sure they would not do so without good reasoning (funding or license deal close and/or to increase value for a future agreement).
I'm still optimistic that they will announce a pleasant surprise in the financing arena before the shareholder meeting next week.